Fosun International Limited

Fosun International Limited is a Chinese multinational conglomerate holding company established in 1992. Headquartered in Shanghai, China, with a registered office in Hong Kong, the company's mission is to create happier lives for families worldwide. Fosun operates as a global innovation-driven consumer group, focusing on four primary business segments: Health, Happiness, Wealth, and Intelligent Manufacturing.

The company's diverse portfolio spans various industries, including healthcare, consumer goods, tourism, financial services, and intelligent manufacturing. Key subsidiaries and brands include Fosun Pharma (pharmaceuticals, medical devices, healthcare services), Yuyuan (consumer goods), Fosun Insurance Portugal (insurance), and Fosun Tourism Group, which notably includes Club Med. These core entities collectively contribute a significant portion of the group's total revenue.

In recent news, Fosun International's MSCI ESG rating was upgraded to AAA in March 2026, marking its first time achieving the highest rating. The company also renewed a strategic cooperation agreement with HSBC China in March 2026 to support its global operations and growth strategies. For the 2025 fiscal year, Fosun International reported solid financial performance with total revenue reaching RMB173.43 billion, demonstrating strong momentum in its core industries and a focus on innovation and globalization. The leadership team includes Guo Guangchang as Chairman, Wang Qunbin as Co-Chairman, and Chen Qiyu and Xu Xiaoliang as Co-CEOs.